论文部分内容阅读
目的观察26例急性病毒性心肌炎患者经左卡尼汀联合黄芪注射液治疗的临床效果。方法选取我院收治的52例急性病毒性心肌炎(AVM)患者为研究对象,采取双盲法均分为观察组和对照组,各26例。观察组患者采用左卡尼汀联合黄芪注射液进行治疗,对照组患者采用常规疗法联合左卡尼汀进行治疗,比较两组患者的临床疗效。结果观察组患者的治疗总有效率为92.31%,明显高于对照组患者的73.08%(P<0.05)。观察组患者的心肌酶指标及cTnl水平明显优于对照组(P<0.05)。结论左卡尼汀联合黄芪注射液治疗病毒性心肌炎能改善患者的心肌酶谱,提高治疗有效率,临床效果显著。
Objective To observe the clinical effect of levocarnitine and astragalus injection in 26 patients with acute viral myocarditis. Methods Fifty-two patients with acute viral myocarditis (AVM) admitted to our hospital were enrolled in this study. All patients were divided into observation group and control group by double-blind method, with 26 cases in each group. Patients in the observation group were treated with levocarnitine and astragalus injection, while patients in the control group were treated with conventional therapy combined with levocarnitine. The clinical efficacy was compared between the two groups. Results The total effective rate of the observation group was 92.31%, which was significantly higher than that of the control group (73.08%, P <0.05). The level of myocardial enzyme and cTnl in the observation group was significantly better than that in the control group (P <0.05). Conclusion Levocarnitine combined with Astragalus injection in the treatment of viral myocarditis can improve myocardial enzymes in patients, improve the efficiency of treatment, the clinical effect is significant.